Profile picture

Professor Peter Van Der Meer

University Medical Centre Groningen, Groningen (Netherlands (The))
Membership: FESC Member HFA Member
Follow
Biography
Peter van der Meer is a cardiologist, chair of the Department of Experimental Cardiology and professor of Heart Failure and Translational Cardiology at the University of Groningen. Professor van der Meer received both his MD and PhD cum laude and completed a postdoctoral fellowship at Harvard Medical School, Boston, MA, USA. He authored >300 manuscripts, has an H-index of >100 and was member of the 2022 ESC CardioOncology guidelines and is member of the ESC/HFA working group on PeriPartum CardioMyopathy. He is a member of several steering committees of large phase 3 trials. His research is funded by national and international grants including an ERC CoG grant. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics. His research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies.
Logo ESC

Contributor content

Acute coronary syndrome in patients with cancer
Session
Acute coronary syndrome in patients with cancer
31 August 2026
Heart failure: diagnosis and therapy
Session
Heart failure: diagnosis and therapy
30 August 2026
Coronary disease and cardiovascular toxicity in patients with cancer
Session
Coronary disease and cardiovascular toxicity in patients with cancer
30 August 2026
Frontiers in amyloid heart disease: from treatment to cure
Session
Frontiers in amyloid heart disease: from treatment to cure
28 August 2026
ESC councils’ perspectives: cardio-oncology priorities and future evidence needs
Session
ESC councils’ perspectives: cardio-oncology priorities and future evidence needs
20 June 2026
From clone control to fibril clearance: an amyloidosis update for daily practice
Session
From clone control to fibril clearance: an amyloidosis update for daily practice
19 June 2026
New insights from animal models of heart failure and cardiomyopathy
Session
New insights from animal models of heart failure and cardiomyopathy
11 May 2026
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
Session
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
11 May 2026
Late-Breaking Clinical Science: spectrum of cardiomyopathies
Session
Late-Breaking Clinical Science: spectrum of cardiomyopathies
31 August 2025
Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure?
Session
Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure?
30 August 2025